TME Pharma NV banner

TME Pharma NV
PAR:ALTME

Watchlist Manager
TME Pharma NV Logo
TME Pharma NV
PAR:ALTME
Watchlist
Price: 0.073 EUR -0.14% Market Closed
Market Cap: €6.9m

Profitability Summary

TME Pharma NV's profitability score is 31/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score
31/100
Profitability
Score

Margins

Earnings Waterfall
TME Pharma NV

Margins Comparison
TME Pharma NV Competitors

Country Company Market Cap Operating
Margin
Net
Margin
DE
TME Pharma NV
PAR:ALTME
6.9m EUR
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
399.2B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
202.4B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
188.1B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.1B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
71.4B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44.2B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
TME Pharma NV Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
TME Pharma NV
PAR:ALTME
6.9m EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
399.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
202.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
188.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.1B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
71.4B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44.2B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
TME Pharma NV

Last Value
3-Years Average
FCF Margin
Conversion Rate